Skip to content

Dr Wies Vanderbruggen

Active
Private limited companyfounded 20242 yrs activeRosalialaan 1, 2650 Edegem, BelgiumKBO/BCE: BE 1012.936.059
Summary

The computed 12-month bankruptcy probability of Dr Wies Vanderbruggen is 3.7% (moderate). The 2025 annual accounts show equity of €18k and a net result of €23k. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
69 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+100
Solvency76▲+76
Growth78
Track record82
Bankruptcy probability, 12 months
3.7% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity ample (current ratio 1.9 against 0.64 in 2024; short-term debt: 48% and cash: 53.8% of total assets), and 48.5% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
51.5%
Return on assets
66.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 d early
2024
27 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€18k
2024 · €-5k
2024: €-5k
2024 → 2025
Total assets
€35k▲ 125%
2024 · €15k
2024: €15k
2024 → 2025
Net result
€23k
2024 · €-8k
2024: €-8k
2024 → 2025
Working capital
€15k
2024 · €-7k
2024: €-7k
2024 → 2025
Multi-year overview
Available amounts per fiscal year
Line20242025Trend
Equity€-5k-€18k
Operating result€-7k-€34k
Net result€-8k-€23k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-20k€0€20k€40kOperating result 2024: €-7k€-7kNet result 2024: €-8k€-8kOperating result 2025: €34k€34kNet result 2025: €23k€23k20242025€-20k€0€20k€40kOperating result 2024: €-7k€-7kNet result 2024: €-8k€-7.6kOperating result 2025: €34k€34kNet result 2025: €23k€23k20242025
The operating result returns to profit in 2025: €34k after a loss of €7k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €35k
Fixed assets €3k ▲ 33.8%
Current assets €32k ▲ 141%
Equity and liabilities €35k
Equity €18k
Debt €17k
Debt finances 48.5% of the balance-sheet total.
Key figures and ratios
2025 value · change against 2024
EBITDA
€35k
2024 · €-7k
Cash flow
€24k
2024 · €-8k
Current ratio
1.90
2024 · 0.64
Debt to equity
0.94
2024 · -4.04
ROE
128.4%
ROA
66.1%
2024 · -49.1%
Interest coverage
19.03
2024 · -14.41
Debt ≤ 1 year
€17k
2024 · €21k
Income taxes
€9k
2024 · €65
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€15k€35k
Fixed assets21/28€2k€3k
Tangible fixed assets22/27€2k€3k
Plant, machinery and equipment23€2k€3k
Current assets29/58€13k€32k
Amounts receivable within one year40/41-€11k
Other amounts receivable41-€11k
Cash at bank and in hand54/58€13k€19k
Deferred charges and accrued income490/1-€2k
Equity and liabilities
Total equity and liabilities10/49€15k€35k
Equity10/15€-5k€18k
Contributions10/11€3k€3k=
Reserves13-€15k
Distributable reserves133-€15k
Profit (loss) carried forward14€-8k€0
Amounts payable17/49€21k€17k
Amounts payable within one year42/48€21k€17k
Trade debts44€538€91
Suppliers440/4€538€91
Taxes, remuneration and social security45€65€4k
Taxes450/3€65€4k
Other amounts payable47/48€20k€12k
Accrued charges and deferred income492/3-€174
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€72€575
Other operating charges640/8€50€570
Gross operating margin9900€-7k€35k
Operating profit (loss)9901€-7k€34k
Financial charges65/66B€484€2k
Recurring financial charges65€484€2k
Profit (loss) for the period before taxes9903€-8k€32k
Income taxes67/77€65€9k
Profit (loss) for the period9904€-8k€23k
Profit (loss) for the period to be appropriated9905€-8k€23k
Appropriation of the result
Profit (loss) to be appropriated9906€-8k€15k
Profit (loss) brought forward from the previous period14P-€-8k
Transfer to equity691/2-€15k
To other reserves6921-€15k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Back to profitnet €23k
Net result €23k after one loss-making year.
31-12
Financial Liquidity triplescurrent ratio 1.90
Current ratio from 0.64 to 1.90; short-term debt falls from €21k to €17k.
04-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Edegem · 2 establishment units since 2024
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rosalialaan 12650 Edegem
Ground area
4.6 ha
Building footprint
2,529 m²
Volume, LiDAR
19,301 m³
2 parcels, Flanders · tallest building 22.8 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Dr Wies Vanderbruggen
Rosalialaan 1, 2650 EdegemSpecialist medical practice
since 20242.363.171.210
Dr Wies Vanderbruggen
Augustijnslei 100, 2930 BrasschaatSpecialist medical practice
since 20242.363.363.428
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11324D0001/00V000 Flanders 4.5 ha 1 · 2,435 m² 22.8 m · 2 fl.
11472C0438/00A000 Flanders 363 m² 1 · 94 m² 5.5 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded29-08-2024
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.